| Q63230054 | 2019 update of the WSES guidelines for management of () infection in surgical patients |
| Q36091394 | A Canadian Working Group report on fecal microbial therapy: microbial ecosystems therapeutics |
| Q27335693 | A Comparison of Current Guidelines of Five International Societies on Clostridium difficile Infection Management. |
| Q92642001 | A Complex Scenario of Nonsteroidal Anti-inflammatory Drugs Induced Prostaglandin E2 Production and Gut Microbiota Alteration in Clostridium difficile-Infected Mice |
| Q92267912 | A Phase 2 Study Evaluating the Safety, Tolerability, and Immunogenicity of Two 3-Dose Regimens of a Clostridium difficile Vaccine in Healthy US Adults Aged 65 to 85 Years |
| Q64104118 | A Role for Tetracycline Selection in Recent Evolution of Agriculture-Associated PCR Ribotype 078 |
| Q36255845 | A chimeric protein comprising the glucosyltransferase and cysteine proteinase domains of toxin B and the receptor binding domain of toxin A induces protective immunity against Clostridium difficile infection in mice and hamsters |
| Q42228641 | A cluster of fulminant Clostridium difficile colitis in an intensive care unit in Italy |
| Q92152991 | A global to local genomics analysis of Clostridioides difficile ST1/RT027 identifies cryptic transmission events in a northern Arizona healthcare network |
| Q41434690 | A mixture of functionally oligoclonal humanized monoclonal antibodies that neutralize Clostridium difficile TcdA and TcdB with high levels of in vitro potency shows in vivo protection in a hamster infection model. |
| Q40185692 | A multicenter, retrospective, case-cohort study of the epidemiology and risk factors for Clostridium difficile infection among cord blood transplant recipients. |
| Q34257705 | A multicentre randomised controlled trial evaluating lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea in older people admitted to hospital: the PLACIDE study protocol. |
| Q92951993 | A phase 1 randomized study assessing safety and immunogenicity of two 3-dose regimens of a Clostridium difficile vaccine in healthy older Japanese adults |
| Q39906601 | A phase 1, placebo-controlled, randomized study of the safety, tolerability, and immunogenicity of a Clostridium difficile vaccine administered with or without aluminum hydroxide in healthy adults |
| Q26823599 | Acid suppression and the risk of Clostridium difficile infection |
| Q58556398 | Activates Human Mucosal-Associated Invariant T Cells |
| Q92578798 | Adaptation of host transmission cycle during Clostridium difficile speciation |
| Q39347528 | Adherence to clinical practice guidelines for the management of Clostridium difficile infection in Japan: a multicenter retrospective study |
| Q99207543 | Advanced age and increased CRP concentration are independent risk factors associated with Clostridioides difficile infection mortality |
| Q40723890 | Age and gender differences in Clostridium difficile-related hospitalization trends in Madrid (Spain) over a 12-year period. |
| Q42279664 | All-cause and disease-specific mortality in hospitalized patients with Clostridium difficile infection: a multicenter cohort study |
| Q26778130 | An Update on Clostridium difficile Toxinotyping |
| Q35598962 | An enhanced DNA fingerprinting service to investigate potential Clostridium difficile infection case clusters sharing the same PCR ribotype |
| Q38844052 | An exploratory study to evaluate Clostridium difficile polymerase chain reaction ribotypes and infection outcomes |
| Q95576106 | An in silico survey of Clostridioides difficile extrachromosomal elements |
| Q37992487 | An overview of the diagnosis and management of Clostridium difficile infection |
| Q34322185 | Analysis of a Clostridium difficile PCR ribotype 078 100 kilobase island reveals the presence of a novel transposon, Tn6164 |
| Q42288669 | Analysis of metronidazole susceptibility in different Clostridium difficile PCR ribotypes |
| Q38208794 | Antibodies for treatment of Clostridium difficile infection |
| Q42274443 | Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications |
| Q36835352 | Antimicrobial susceptibility profiles of human and piglet Clostridium difficile PCR-ribotype 078. |
| Q50157269 | Assessing the burden of C. difficile infection in low- and middle-income countries |
| Q38635793 | Association between omeprazole use and Clostridium difficile infection among hospitalized patients: A case-control study of the Saudi population |
| Q42280606 | Automated detection of toxigenic Clostridium difficile in clinical samples: isothermal tcdB amplification coupled to array-based detection |
| Q36571896 | Bacteriophage Combinations Significantly Reduce Clostridium difficile Growth In Vitro and Proliferation In Vivo |
| Q58780929 | Bacteriophages Contribute to Shaping Species |
| Q59126532 | Bezlotoxumab Is Associated With a Reduction in Cumulative Inpatient-Days: Analysis of the Hospitalization Data From the MODIFY I and II Clinical Trials |
| Q51740247 | Bezlotoxumab for prevention of recurrent C. difficile infection in patients at increased risk for recurrence. |
| Q35106011 | Broad coverage of genetically diverse strains of Clostridium difficile by actoxumab and bezlotoxumab predicted by in vitro neutralization and epitope modeling |
| Q35692352 | Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe |
| Q30196898 | Burden of Nursing Home-Onset Clostridium difficile Infection in the United States: Estimates of Incidence and Patient Outcomes |
| Q45143059 | C. difficile ribotype 027 or 176? |
| Q37125211 | Challenges for standardization of Clostridium difficile typing methods |
| Q34510386 | Characterisation of Clostridium difficile biofilm formation, a role for Spo0A. |
| Q38837163 | Characterisation of Clostridium difficile strains isolated from Groote Schuur Hospital, Cape Town, South Africa |
| Q36996846 | Characterization of Clostridium difficile Strains in British Columbia, Canada: A Shift from NAP1 Majority (2008) to Novel Strain Types (2013) in One Region |
| Q38848131 | Characterization of temperate phages infecting Clostridium difficile isolates of human and animal origins. |
| Q60045427 | Characterization of the virulence of a non-RT027, non-RT078 and binary toxin-positive Clostridium difficile strain associated with severe diarrhea |
| Q36004544 | Chronic kidney disease and end-stage renal disease are risk factors for poor outcomes of Clostridium difficile infection: a systematic review and meta-analysis. |
| Q28354123 | Clinical Characteristics and Treatment Outcomes of Clostridium difficile Infections by PCR Ribotype 017 and 018 Strains |
| Q56225357 | Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) |
| Q26778127 | Clinical Utility of Laboratory Detection of Clostridium difficile Strain BI/NAP1/027 |
| Q37192173 | Clinical and Microbiologic Characteristics of Clostridium difficile Infection Caused by Binary Toxin Producing Strain in Korea |
| Q34263649 | Clinical and microbiologic characteristics of tcdA-negative variant Clostridium difficile infections |
| Q36402112 | Clinical features and characteristics of Clostridium difficile PCR-ribotype 176 infection: results from a 1-year university hospital internal ward study |
| Q91962993 | Clostridioides (Clostridium) Difficile in Food-Producing Animals, Horses and Household Pets: A Comprehensive Review |
| Q92228601 | Clostridioides difficile infection in the Asia-Pacific region |
| Q90648513 | Clostridioides difficile infections in the intensive care unit: a monocentric cohort study |
| Q89483643 | Clostridioides difficile ribotype 106: A systematic review of the antimicrobial susceptibility, genetics, and clinical outcomes of this common worldwide strain |
| Q91834131 | Clostridioides difficile ribotypes isolated from domestic environment and from patients in Bangladesh |
| Q52564641 | Clostridium difficile - From Colonization to Infection. |
| Q44221762 | Clostridium difficile 027 increasing detection in a teaching hospital in Rome, Italy |
| Q34520307 | Clostridium difficile 027 infection in Central Italy |
| Q34462633 | Clostridium difficile 027-associated pseudomembranous colitis after short-term treatment with cefuroxime and cephalexin in an elderly orthopedic patient: a case report |
| Q38558966 | Clostridium difficile Diarrhea in the Elderly: Current Issues and Management Options |
| Q89908699 | Clostridium difficile Infection: An Epidemiology Update |
| Q53692769 | Clostridium difficile Infections: A Global Overview of Drug Sensitivity and Resistance Mechanisms. |
| Q50968625 | Clostridium difficile O27 colitis: hospital-onset but community-acquired. |
| Q35652292 | Clostridium difficile PCR Ribotype 018, a Successful Epidemic Genotype |
| Q39533078 | Clostridium difficile PCR ribotypes 001 and 176 - the common denominator of C. difficile infection epidemiology in the Czech Republic, 2014. |
| Q54239070 | Clostridium difficile Toxoid Vaccine Candidate Confers Broad Protection against a Range of Prevalent Circulating Strains in a Nonclinical Setting. |
| Q37391438 | Clostridium difficile associated risk of death score (CARDS): a novel severity score to predict mortality among hospitalised patients with C. difficile infection |
| Q33728296 | Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance |
| Q54298960 | Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains. |
| Q41868062 | Clostridium difficile genotypes in piglet populations in Germany |
| Q34209440 | Clostridium difficile genotypes other than ribotype 078 that are prevalent among human, animal and environmental isolates |
| Q45354724 | Clostridium difficile healthcare-associated epidemics |
| Q38233881 | Clostridium difficile in Children: To Treat or Not to Treat? |
| Q40923400 | Clostridium difficile in Crete, Greece: epidemiology, microbiology and clinical disease |
| Q38074514 | Clostridium difficile in foods and animals: history and measures to reduce exposure |
| Q92929119 | Clostridium difficile in wild rodents and insectivores in the Netherlands |
| Q60500782 | Clostridium difficile infection |
| Q37250343 | Clostridium difficile infection after adult autologous stem cell transplantation: a multicenter study of epidemiology and risk factors. |
| Q43088433 | Clostridium difficile infection associated with pig farms. |
| Q44667578 | Clostridium difficile infection diagnosis in a paediatric population: comparison of methodologies |
| Q30605607 | Clostridium difficile infection in Italian urban hospitals: data from 2006 through 2011. |
| Q37003725 | Clostridium difficile infection in a French university hospital: Eight years of prospective surveillance study |
| Q42242661 | Clostridium difficile infection in hospitalized patients at university clinical center tuzla, bosnia and herzegovina: a 4 year experience |
| Q37870297 | Clostridium difficile infection in humans and animals, differences and similarities |
| Q38105281 | Clostridium difficile infection in patients with HIV/AIDS. |
| Q38600142 | Clostridium difficile infection in patients with liver disease: a review |
| Q38268703 | Clostridium difficile infection in the postcolectomy patient |
| Q37879185 | Clostridium difficile infection: a comprehensive review |
| Q30316981 | Clostridium difficile infection: guideline-based diagnosis and treatment |
| Q38757841 | Clostridium difficile infections in Finland, 2008-2015: trends, diagnostics and ribotypes |
| Q30244040 | Clostridium difficile infections in geriatric patients |
| Q64951652 | Clostridium difficile ribotype 017 - characterization, evolution and epidemiology of the dominant strain in Asia. |
| Q37026536 | Clostridium difficile ribotype diversity at six health care institutions in the United States |
| Q35952584 | Clostridium difficile ribotypes in Austria: a multicenter, hospital-based survey |
| Q36450352 | Clostridium difficile ribotypes in humans and animals in Brazil |
| Q38154925 | Clostridium difficile surveillance: harnessing new technologies to control transmission |
| Q64240941 | Clostridium difficile-associated Diarrhea in Developing Countries: A Systematic Review and Meta-Analysis |
| Q40065547 | Clostridium difficile-associated deaths from 2013-2016 in Munich and Nuremberg : Reporting behavior and patient characteristics |
| Q36134269 | Clostridium difficile: New Insights into the Evolution of the Pathogenicity Locus |
| Q38017389 | Clostridium difficile: development of a novel candidate vaccine |
| Q34162219 | Clostridium: transmission difficile? |
| Q52622824 | Coinfection with 2 Clostridium difficile ribotypes in China: A case report. |
| Q37288133 | Community- and Healthcare-Associated Clostridium difficile Infections, Finland, 2008-2013(1). |
| Q92028651 | Community-Onset Clostridioides Difficile Infection in Hospitalized Patients in The Netherlands |
| Q37655456 | Community-acquired Clostridium difficile infection: an increasing public health threat |
| Q89736759 | Comparative Study of Clostridium difficile Clinical Detection Methods in Patients with Diarrhoea |
| Q40790084 | Complications of Hospital-Onset Healthcare Facility-Associated Clostridium difficile Infections Among Veterans |
| Q38192010 | Control of Clostridium difficile infection in the hospital setting |
| Q38538221 | Controversies Around Epidemiology, Diagnosis and Treatment of Clostridium difficile Infection |
| Q30235278 | Conventional and alternative treatment approaches for Clostridium difficile infection |
| Q41868020 | Correlation between Clostridium difficile bacterial load, commercial real-time PCR cycle thresholds, and results of diagnostic tests based on enzyme immunoassay and cell culture cytotoxicity assay. |
| Q36113668 | Cost of hospital management of Clostridium difficile infection in United States-a meta-analysis and modelling study |
| Q64062094 | Cost savings following faecal microbiota transplantation for recurrent infection |
| Q36280168 | Cost-effectiveness in Clostridium difficile treatment decision-making |
| Q36757254 | Cross-sectional study reveals high prevalence of Clostridium difficile non-PCR ribotype 078 strains in Australian veal calves at slaughter |
| Q34285444 | Current status of Clostridium difficile infection epidemiology |
| Q41655280 | DNA microarray-based PCR ribotyping of Clostridium difficile |
| Q34707553 | Depression, antidepressant medications, and risk of Clostridium difficile infection |
| Q38687899 | Description and validation of a new automated surveillance system for Clostridium difficile in Denmark |
| Q90732886 | Design and Expression of Specific Hybrid Lantibiotics Active Against Pathogenic Clostridium spp |
| Q35095564 | Development and validation of an internationally-standardized, high-resolution capillary gel-based electrophoresis PCR-ribotyping protocol for Clostridium difficile |
| Q41650253 | Diagnosis of Clostridium difficile: real-time PCR detection of toxin genes in faecal samples is more sensitive compared to toxigenic culture. |
| Q26777157 | Diagnostic accuracy of loop-mediated isothermal amplification in detection of Clostridium difficile in stool samples: a meta-analysis |
| Q40130826 | Diagnostic workup and therapy of infectious diarrhea. Current standards |
| Q37293591 | Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection |
| Q41631010 | Different antibiotic resistance and sporulation properties within multiclonal Clostridium difficile PCR ribotypes 078, 126, and 033 in a single calf farm. |
| Q54548493 | Difficile indeed. |
| Q26741585 | Dissimilar Fitness Associated with Resistance to Fluoroquinolones Influences Clonal Dynamics of Various Multiresistant Bacteria |
| Q28084700 | Diversity and Evolution in the Genome of Clostridium difficile |
| Q50042760 | Diversity and antimicrobial activity of Pseudovibrio spp. from Irish marine sponges |
| Q40595939 | Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013. |
| Q40554081 | Draft Genome Sequence of Clostridium difficile Belonging to Ribotype 018 and Sequence Type 17 |
| Q40604220 | Draft Genome Sequence of Clostridium difficile Strain IT1118, an Epidemic Isolate Belonging to the Emerging PCR Ribotype 018. |
| Q40784614 | Economic burden of Clostridium difficile associated diarrhoea: a cost-of-illness study from a German tertiary care hospital. |
| Q36307202 | Economic burden of Clostridium difficile in five hospitals of the Florence health care system in Italy |
| Q97426271 | Economic evaluation of Faecal microbiota transplantation compared to antibiotics for the treatment of recurrent Clostridioides difficile infection |
| Q48319188 | Editorial commentary: Changing epidemiology of Clostridium difficile and emergence of new virulent strains |
| Q40459481 | Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis. |
| Q89884739 | Effect of sub-MIC values of metronidazole, ciprofloxacin, and imipenem on the growth and toxin production in Clostridioides difficile |
| Q89514920 | Effectiveness and cost-effectiveness of a Clostridium difficile vaccine candidate in a hospital setting |
| Q89984713 | Effects of co-infection on the clinical outcomes of Clostridium difficile infection |
| Q33831557 | Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study |
| Q41158827 | Efficacy of alternative fidaxomicin dosing regimens for treatment of simulated Clostridium difficile infection in an in vitro human gut model |
| Q50041908 | Efficacy of an Optimised Bacteriophage Cocktail to Clear Clostridium difficile in a Batch Fermentation Model |
| Q36708973 | Emergence and global spread of epidemic healthcare-associated Clostridium difficile |
| Q41195681 | Emergence and spread of predominantly community-onset Clostridium difficile PCR ribotype 244 infection in Australia, 2010 to 2012. |
| Q36997707 | Emergence of Clostridium difficile infection in tuberculosis patients due to a highly rifampicin-resistant PCR ribotype 046 clone in Poland |
| Q93016993 | Eosinopenia and Binary Toxin Increase Mortality in Hospitalized Patients With Clostridioides difficile Infection |
| Q36055810 | Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach |
| Q31138398 | Epidemiology and Recurrence Rates of Clostridium difficile Infections in Germany: A Secondary Data Analysis |
| Q28073805 | Epidemiology and Risk Factors for Community-Associated Clostridium difficile Infection: A Narrative Review |
| Q36186012 | Epidemiology and outcome of Clostridium difficile infections in patients hospitalized in Internal Medicine: findings from the nationwide FADOI-PRACTICE study |
| Q34027474 | Epidemiology of Clostridium difficile infection |
| Q36826679 | Epidemiology of Clostridium difficile infection and risk factors for unfavorable clinical outcomes: results of a hospital-based study in Barcelona, Spain |
| Q37033281 | Epidemiology of Clostridium difficile infection in Asia |
| Q41684190 | Epidemiology of Clostridium difficile infection in two tertiary-care hospitals in Perth, Western Australia: a cross-sectional study |
| Q41095363 | Epidemiology of Clostridium difficile infection: results of a hospital-based study in Krakow, Poland |
| Q44041662 | Epidemiology of Clostridium difficile on a veal farm: prevalence, molecular characterization and tetracycline resistance |
| Q58376524 | Epidemiology of Clostridium difficile-associated disease in internal medicine wards in northern Italy |
| Q38068605 | Epidemiology, diagnosis and treatment of Clostridium difficile infection |
| Q49638608 | Equivalent Performance of the Cobas® Cdiff Test for Use on the Cobas® Liat® System and the Cobas® 4800 System |
| Q36465447 | Evaluation of Xpert C. difficile, BD MAX Cdiff, IMDx C. difficile for Abbott m2000, and Illumigene C. difficile Assays for Direct Detection of Toxigenic Clostridium difficile in Stool Specimens |
| Q43817719 | Evaluation of linezolid for the treatment of Clostridium difficile infection caused by epidemic strains using an in vitro human gut model |
| Q51353976 | Evaluation of three enzyme immunoassays and a loop-mediated isothermal amplification test for the laboratory diagnosis of Clostridium difficile infection. |
| Q64109739 | Evolutionary and Genomic Insights into Sequence Type 11: a Diverse Zoonotic and Antimicrobial-Resistant Lineage of Global One Health Importance |
| Q34391822 | Evolutionary history of the Clostridium difficile pathogenicity locus |
| Q35964926 | Excess Mortality Attributable to Clostridium difficile and Risk Factors for Infection in an Historic Cohort of Hospitalised Patients Followed Up in the United Kingdom Death Register |
| Q35172641 | Exposure of neutralizing epitopes in the carboxyl-terminal domain of TcdB is altered by a proximal hypervariable region. |
| Q35273341 | Extended multilocus variable-number tandem-repeat analysis of Clostridium difficile correlates exactly with ribotyping and enables identification of hospital transmission |
| Q49610079 | Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial |
| Q36311457 | Factors Associated With Complications of Clostridium difficile Infection in a Multicenter Prospective Cohort |
| Q54417278 | Faecal microbiota transplantation and bacteriotherapy for recurrent Clostridium difficile infection: a retrospective evaluation of 31 patients. |
| Q47632083 | Fecal calprotectin in management of Clostridium difficile infection: a longitudinal study. |
| Q36379088 | Fecal microbiota transplantation in relapsing Clostridium difficile infection |
| Q26765214 | Fecal microbiota transplantation: in perspective |
| Q36647979 | Fecal transplant in refractory Clostridium difficile colitis |
| Q61713430 | Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial |
| Q34798381 | First Polish outbreak of Clostridium difficile ribotype 027 infections among dialysis patients |
| Q91770291 | Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study |
| Q92218161 | From Root to Tips: Sporulation Evolution and Specialization in Bacillus subtilis and the Intestinal Pathogen Clostridioides difficile |
| Q99558111 | GABAergic but not Antidepressant Medications Increase Risk for Clostridioides difficile Infection in a National Cohort of Veterans |
| Q41690945 | Genetic relatedness between Japanese and European isolates of Clostridium difficile originating from piglets and their risk associated with human health |
| Q37578190 | Genome Analysis of Clostridium difficile PCR Ribotype 014 Lineage in Australian Pigs and Humans Reveals a Diverse Genetic Repertoire and Signatures of Long-Range Interspecies Transmission |
| Q93221196 | Genome Location Dictates the Transcriptional Response to PolC Inhibition in Clostridium difficile |
| Q36635701 | Genome-Based Infection Tracking Reveals Dynamics of Clostridium difficile Transmission and Disease Recurrence |
| Q91692777 | Genomic Delineation of Zoonotic Origins of Clostridium difficile |
| Q36123790 | Growth Patterns of Clostridium difficile - Correlations with Strains, Binary Toxin and Disease Severity: A Prospective Cohort Study. |
| Q98465499 | High Prevalence of Genetically Related Clostridium Difficile Strains at a Single Hemato-Oncology Ward Over 10 Years |
| Q92573412 | High frequency of toxigenic Clostridium difficile and Clostridium perfringens coinfection among diarrheic patients at health care facility-onset (HCFO) and community-onset (CO) centers in Bogotá, Colombia |
| Q34131173 | High prevalence of Clostridium difficile colonization among nursing home residents in Hesse, Germany |
| Q43711757 | Hospital Clostridium difficile infection testing rates: is "don't ask, don't tell" at play? |
| Q89908729 | Hospital Infection Control: Clostridioides difficile |
| Q38603025 | Hospital-acquired Clostridium difficile infection in Mainland China: A seven-year (2009-2016) retrospective study in a large university hospital |
| Q40357181 | Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013. |
| Q38969987 | Host response to Clostridium difficile infection: Diagnostics and detection |
| Q41131155 | How do Clostridium difficile infections affect nurses' everyday hospital work: A qualitative study |
| Q38141579 | Hype or hypervirulence: a reflection on problematic C. difficile strains. |
| Q64232660 | Hypoalbuminemia as predictor of recurrence of Clostridium difficile infection |
| Q34456650 | ICU-Onset Clostridium difficile infection in a university hospital in China: a prospective cohort study |
| Q33693904 | Identification of novel risk factors for community-acquired Clostridium difficile infection using spatial statistics and geographic information system analyses |
| Q92306236 | Impact of a training program on the surveillance of Clostridioides difficile infection |
| Q41294771 | Impact of clinical awareness and diagnostic tests on the underdiagnosis of Clostridium difficile infection |
| Q38716945 | Impact of recurrent Clostridium difficile infection: hospitalization and patient quality of life |
| Q51317741 | Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. |
| Q41148829 | In vitro susceptibility of Clostridium difficile to SMT19969 and comparators, as well as the killing kinetics and post-antibiotic effects of SMT19969 and comparators against C. difficile |
| Q36658426 | Incidence and Clinical Outcomes of Clostridium difficile Infection after Treatment with Tuberculosis Medication |
| Q42605505 | Increased hospital length of stay attributable to Clostridium difficile infection in patients with four co-morbidities: an analysis of hospital episode statistics in four European countries |
| Q39755382 | Increasing incidence of Clostridium difficile infections: results from a 5-year retrospective study in a large teaching hospital in the Italian region with the oldest population. |
| Q38691798 | Increasing incidence of Clostridium difficile ribotype 001 associated with severe course of the infection and previous fluoroquinolone use in the Czech Republic, 2015. |
| Q64120376 | Independent Microevolution Mediated by Mobile Genetic Elements of Individual Clostridium difficile Isolates from Clade 4 Revealed by Whole-Genome Sequencing |
| Q40182314 | Individualized treatment strategies for Clostridium difficile infections |
| Q41007833 | Infection with Toxin A-Negative, Toxin B-Negative, Binary Toxin-Positive Clostridium difficile in a Young Patient with Ulcerative Colitis |
| Q90324385 | Inpatient Expenditures Attributable to Hospital-Onset Clostridium difficile Infection: A Nationwide Case-Control Study in Japan |
| Q33909227 | International Clostridium difficile animal strain collection and large diversity of animal associated strains |
| Q51581458 | Intestinal Epithelial Cell Response to Clostridium difficile Flagella. |
| Q60301191 | Intrinsic Class D β-Lactamases of |
| Q38638507 | Is there a relationship between the presence of the binary toxin genes in Clostridium difficile strains and the severity of C. difficile infection (CDI)? |
| Q31105341 | Isolation of C. difficile Carriers Alone and as Part of a Bundle Approach for the Prevention of Clostridium difficile Infection (CDI): A Mathematical Model Based on Clinical Study Data |
| Q35035950 | Laboratory detection of Clostridium difficile in piglets in Australia |
| Q34429629 | Long-Term Clinical Outcome of Clostridium difficile Infection in Hospitalized Patients: A Single Center Study |
| Q37287137 | Longitudinal Investigation of Carriage Rates, Counts, and Genotypes of Toxigenic Clostridium difficile in Early Infancy. |
| Q36208584 | Loss of Microbiota-Mediated Colonization Resistance to Clostridium difficile Infection With Oral Vancomycin Compared With Metronidazole |
| Q41251501 | Low Prevalence of Clostridium difficile in Slaughter Pigs in Korea. |
| Q34187096 | Macro and micro diversity of Clostridium difficile isolates from diverse sources and geographical locations |
| Q35896384 | Mechanisms of hypervirulent Clostridium difficile ribotype 027 displacement of endemic strains: an epidemiological model |
| Q55311464 | Mechanistic Insights in the Success of Fecal Microbiota Transplants for the Treatment of Clostridium difficile Infections. |
| Q92392559 | Method comparison for the direct enumeration of bacterial species using a chemostat model of the human colon |
| Q52801676 | Microbial Preparations (Probiotics) for the Prevention of Clostridium difficile Infection in Adults and Children: An Individual Patient Data Meta-analysis of 6,851 Participants. |
| Q34284603 | Mini-review: Epidemiology and zoonotic potential of multiresistant bacteria and Clostridium difficile in livestock and food |
| Q34786520 | Modelling the transmission of healthcare associated infections: a systematic review |
| Q54211969 | Molecular Characterization of Clostridium difficile Isolates in China From 2010 to 2015. |
| Q39038610 | Molecular Epidemiology of Clostridium difficile Infection in Hospitalized Patients in Eastern China |
| Q40935046 | Molecular characterization and antimicrobial susceptibility of Clostridium difficile isolated from rabbits raised for meat production. |
| Q41620586 | Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from a university teaching hospital in Japan |
| Q36326824 | Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolates from two Korean hospitals |
| Q55100322 | Molecular epidemiology of Clostridium difficile in two tertiary care hospitals in Shandong Province, China. |
| Q37264255 | Molecular epidemiology of Clostridium difficile infection in a major chinese hospital: an underrecognized problem in Asia? |
| Q90489435 | Molecular epidemiology of Clostridium difficile isolated from piglets |
| Q86070124 | Molecular epidemiology of Clostridium difficile strains from nosocomial-acquired infections |
| Q38142247 | Molecular methods in the diagnosis of Clostridium difficile infections: an update |
| Q40279012 | Molecular typing and antimicrobial susceptibility testing to six antimicrobials of Clostridium difficile isolates from three Czech hospitals in Eastern Bohemia in 2011-2012. |
| Q39727030 | Multidrug resistance in European Clostridium difficile clinical isolates |
| Q46012656 | Multilocus sequence typing (MLST) analysis of 104 Clostridium difficile strains isolated from China. |
| Q35599031 | Multiplex PCR method for detection of Clostridium difficile tcdA, tcdB, cdtA, and cdtB and internal in-frame deletion of tcdC |
| Q26859965 | Murine models to study Clostridium difficile infection and transmission |
| Q58777719 | National Surveillance for Clostridioides difficile Infection, Sweden, 2009-2016 |
| Q41696807 | Nationwide surveillance study of Clostridium difficile in Australian neonatal pigs shows high prevalence and heterogeneity of PCR ribotypes |
| Q35098190 | New role for human α-defensin 5 in the fight against hypervirulent Clostridium difficile strains |
| Q55405974 | Novel Antimicrobials for the Treatment of Clostridium difficile Infection. |
| Q36060123 | Novel Clostridium difficile Anti-Toxin (TcdA and TcdB) Humanized Monoclonal Antibodies Demonstrate In Vitro Neutralization across a Broad Spectrum of Clinical Strains and In Vivo Potency in a Hamster Spore Challenge Model |
| Q37588571 | Nutrition economic evaluation of a probiotic in the prevention of antibiotic-associated diarrhea |
| Q41392923 | Occurrence of zoonotic clostridia and Yersinia in healthy cattle. |
| Q38583798 | Optimising gut colonisation resistance against Clostridium difficile infection. |
| Q48312394 | Oral teicoplanin versus oral vancomycin for the treatment of severe Clostridium difficile infection: a prospective observational study |
| Q31158719 | Outbreak of Clostridium difficile PCR ribotype 027--the recent experience of a regional hospital. |
| Q57568952 | Outcome ofClostridium difficile-associated disease in solid organ transplant recipients: a prospective and multicentre cohort study |
| Q89618938 | PCR ribotypes of Clostridioides difficile across Texas from 2011 to 2018 including emergence of ribotype 255 |
| Q30452301 | Pathogenic C difficile is here (and everywhere) to stay |
| Q38176852 | Patients' experience and perception of hospital-treated Clostridium difficile infections: a qualitative study |
| Q89794975 | Perception of quality of life in people experiencing or having experienced a Clostridioides difficile infection: a US population survey |
| Q92023289 | Phosphorylation and functionality of CdtR in Clostridium difficile |
| Q104495284 | Phylogenomic analysis of Clostridioides difficile ribotype 106 strains reveals novel genetic islands and emergent phenotypes |
| Q89454312 | Plasmid-mediated metronidazole resistance in Clostridioides difficile |
| Q40091474 | Point-prevalence survey of healthcare facility-onset healthcare-associated Clostridium difficile infection in Greek hospitals outside the intensive care unit: The C. DEFINE study. |
| Q34670270 | Polymerase chain reaction ribotyping of Clostridium difficile isolates in Qatar: a hospital-based study |
| Q33827614 | Poorer outcomes among cancer patients diagnosed with Clostridium difficile infections in United States community hospitals |
| Q51525731 | Portrait Toxigenic Clostridium difficile assay, an isothermal amplification assay detects toxigenic C. difficile in clinical stool specimens. |
| Q35711361 | Predictors and outcomes of readmission for Clostridium difficile in a national sample of medicare beneficiaries |
| Q40941975 | Predominance of Clostridium difficile ribotypes 012, 027 and 046 in a university hospital in Chile, 2012. |
| Q47144217 | Preliminary screening of type IV secretion system in divergent geographic sources of Clostridium difficile |
| Q40404657 | Presence of Clostridium difficile in pig faecal samples and wild animal species associated with pig farms. |
| Q58797243 | Prevalence and Strain Characterization of in Representative Regions of Germany, Ghana, Tanzania and Indonesia - A Comparative Multi-Center Cross-Sectional Study |
| Q56768549 | Prevalence and genotypic characterization of Clostridium difficile from ruminants in Switzerland |
| Q34210895 | Prevalence and molecular characterization of Clostridium difficile isolated from feedlot beef cattle upon arrival and mid-feeding period |
| Q40359443 | Prevalence and molecular epidemiology of Clostridium difficile infection in Thailand. |
| Q35112200 | Prevalence and pathogenicity of binary toxin-positive Clostridium difficile strains that do not produce toxins A and B |
| Q34048138 | Prevalence and risk factors for asymptomatic Clostridium difficile carriage |
| Q57193557 | Prevalence of Clostridium Difficile-Associated Diarrhoea in Hospitalised Patients (Results of a Russian Prospective Multicentre Study) |
| Q91447897 | Prevalence of Clostridium difficile and Clostridium perfringens in Swiss horses with and without gastrointestinal disease and microbiota composition in relation to Clostridium difficile shedding |
| Q57660817 | Prevalence of Colonization and Infection with Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus and of Clostridium difficile Infection in Canadian Hospitals |
| Q34817165 | Prevalence of gastrointestinal Clostridium difficile carriage in Australian sheep and lambs |
| Q38303539 | Probiotics for antibiotic-associated diarrhea: do we have a verdict? |
| Q35867366 | Prospective observational study comparing three different treatment regimes in patients with Clostridium difficile infection |
| Q26828910 | Quality of care delivered to hospitalized inflammatory bowel disease patients |
| Q28258066 | Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection |
| Q26767079 | Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection |
| Q37671489 | Recombinant antigens based on toxins A and B of Clostridium difficile that evoke a potent toxin-neutralising immune response |
| Q34182686 | Recombination drives evolution of the Clostridium difficile 16S-23S rRNA intergenic spacer region |
| Q36547354 | Recombinational switching of the Clostridium difficile S-layer and a novel glycosylation gene cluster revealed by large-scale whole-genome sequencing |
| Q40144431 | Recreational sandboxes for children and dogs can be a source of epidemic ribotypes of Clostridium difficile. |
| Q35685694 | Recurrent Clostridium difficile infection and the microbiome. |
| Q35822541 | Recurrent Clostridium difficile infection: From colonization to cure |
| Q37875055 | Recurrent Clostridium difficile infection: what are the treatment options? |
| Q41127419 | Regional differences in Clostridium difficile infections in relation to fluoroquinolone and proton pump inhibitor use, Finland, 2008-2011. |
| Q36811255 | Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection |
| Q41110387 | Ribotyping of Clostridium difficile strains associated with nosocomial transmission and relapses in a Swedish County |
| Q26747248 | Ridinilazole: a novel therapy for Clostridium difficile infection |
| Q40631036 | Risk Factors for Clostridium Difficile Diarrhea in Patients With Solid Organ Transplantation. |
| Q50054448 | Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study |
| Q41739117 | Risk factors and management of refractory or recurrent clostridium difficile infection in ileal pouch patients |
| Q37724361 | Risk factors for Clostridium difficile infection in surgical patients hospitalized in a tertiary hospital in Belgrade, Serbia: a case-control study |
| Q83731997 | Risk factors for Clostridium difficile toxin-positive diarrhea: a population-based prospective case-control study |
| Q27021390 | Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review |
| Q38334364 | Risk factors for recurrent Clostridium difficile infection: a systematic review and meta-analysis |
| Q35866318 | Risk factors for recurrent hospital-acquired Clostridium difficile infection in a Japanese university hospital |
| Q39372386 | Risk factors for short- and long-term mortality in very old patients with Clostridium difficile infection: A retrospective study |
| Q47632421 | Safety and immunogenicity of Clostridium difficile toxoid vaccine in Japanese adults |
| Q35689261 | Seasonal variations in Clostridium difficile infections are associated with influenza and respiratory syncytial virus activity independently of antibiotic prescriptions: a time series analysis in Quebec, Canada |
| Q36238732 | Seasonality of Clostridium difficile infections in Southern Germany |
| Q37518712 | Sequence similarity of Clostridium difficile strains by analysis of conserved genes and genome content is reflected by their ribotype affiliation |
| Q35035736 | Sequence variation in tcdA and tcdB of Clostridium difficile: ST37 with truncated tcdA is a potential epidemic strain in China |
| Q35043878 | Spo0A differentially regulates toxin production in evolutionarily diverse strains of Clostridium difficile |
| Q33798369 | Strain types and antimicrobial resistance patterns of Clostridium difficile isolates from the United States, 2011 to 2013 |
| Q34419009 | Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 Update |
| Q85920456 | Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 update |
| Q38767322 | Subtyping and antimicrobial susceptibility of Clostridium difficile PCR ribotype 078/126 isolates of human and animal origin. |
| Q52323510 | Subtyping of Clostridium difficile PCR ribotypes 591, 106 and 002, the dominant strain types circulating in Medellin, Colombia. |
| Q55085307 | Successful Fecal Microbiota Transplantation in a Patient with Severe Complicated Clostridium difficile Infection after Liver Transplantation. |
| Q34447678 | Succession in the gut microbiome following antibiotic and antibody therapies for Clostridium difficile |
| Q24618413 | Surgical Management of Clostridium difficile Colitis |
| Q40683812 | Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013-14. |
| Q37628792 | Surveillance of Clostridium difficile Infections: Results from a Six-Year Retrospective Study in Nine Hospitals of a North Italian Local Health Authority |
| Q47103184 | Surveillance of antibiotic resistance among common Clostridium difficile ribotypes in Hong Kong |
| Q39548845 | Survey of Clostridium difficile infection surveillance systems in Europe, 2011. |
| Q40596125 | Survey of diagnostic and typing capacity for Clostridium difficile infection in Europe, 2011 and 2014. |
| Q34468946 | Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice |
| Q34389455 | TcdC does not significantly repress toxin expression in Clostridium difficile 630ΔErm |
| Q55471972 | The Binary Toxin CDT of Clostridium difficile as a Tool for Intracellular Delivery of Bacterial Glucosyltransferase Domains. |
| Q41817325 | The Clostridium difficile spo0A gene is a persistence and transmission factor |
| Q54265880 | The Epidemiology of Community Clostridium difficile Infection: A Five-Year Population-Based Study on the Bailiwick of Jersey, Channel Islands. |
| Q89908707 | The Inflammasome and Type-2 Immunity in Clostridium difficile Infection |
| Q38489324 | The Risks of Incident and Recurrent Clostridium difficile-Associated Diarrhea in Chronic Kidney Disease and End-Stage Kidney Disease Patients: A Systematic Review and Meta-Analysis. |
| Q30276036 | The binary toxin CDT enhances Clostridium difficile virulence by suppressing protective colonic eosinophilia |
| Q30318298 | The changing burden of infectious disease in Europe |
| Q28830191 | The complexity and diversity of the Pathogenicity Locus in Clostridium difficile clade 5 |
| Q38036704 | The continually evolving Clostridium difficile species |
| Q53735645 | The effect of hospital biocide sodium dichloroisocyanurate on the viability and properties of Clostridium difficile spores. |
| Q41225310 | The emergence of Clostridium difficile PCR-ribotype 001 in Slovakia |
| Q33626443 | The emergence of Clostridium difficile infection in Asia: A systematic review and meta-analysis of incidence and impact |
| Q38744998 | The epidemiology of Clostridium difficile infection in a national kidney transplant center. |
| Q40205951 | The evolution of urban C. difficile infection (CDI): CDI in 2009-2011 is less severe and has better outcomes than CDI in 2006-2008. |
| Q64102862 | The first isolation of Clostridium difficile RT078/ST11 from pigs in China |
| Q40224335 | The incidence and clinical symptomatology of Clostridium difficile infections in a community setting in a cohort of Danish patients attending general practice |
| Q42211155 | The prediction of complicated Clostridium difficile infections in children. |
| Q39302972 | The projected effectiveness of Clostridium difficile vaccination as part of an integrated infection control strategy |
| Q90125013 | The recent emergence of a highly related virulent Clostridium difficile clade with unique characteristics |
| Q43684182 | The relation between farm specific factors and prevalence of Clostridium difficile in slaughter pigs. |
| Q47922235 | The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. |
| Q52809285 | The zoonotic potential of Clostridium difficile from small companion animals and their owners. |
| Q55103812 | Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection. |
| Q34338268 | Toxigenic Clostridium difficile PCR ribotypes from wastewater treatment plants in southern Switzerland |
| Q38815414 | Toxin A-negative toxin B-positive ribotype 017 Clostridium difficile is the dominant strain type in patients with diarrhoea attending tuberculosis hospitals in Cape Town, South Africa |
| Q37546536 | Toxin-producing Clostridium difficile strains as long-term gut colonizers in healthy infants |
| Q92906241 | Two-year analysis of Clostridium difficile ribotypes associated with increased severity |
| Q41629539 | Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID). |
| Q42144252 | Using a dog's superior olfactory sensitivity to identify Clostridium difficile in stools and patients: proof of principle study |
| Q36277090 | Utilizing rapid multiple-locus variable-number tandem-repeat analysis typing to aid control of hospital-acquired Clostridium difficile Infection: a multicenter study |
| Q38196682 | Vaccines against Clostridium difficile |
| Q48300202 | Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials |
| Q37475243 | Variability in testing policies and impact on reported Clostridium difficile infection rates: results from the pilot Longitudinal European Clostridium difficile Infection Diagnosis surveillance study (LuCID) |
| Q90087903 | Virulence of new variant strains of Clostridium difficile producing only toxin A or binary toxin in the hamster model |
| Q26795429 | WSES guidelines for management of Clostridium difficile infection in surgical patients |
| Q91906110 | Whole genome analysis reveals new insights into the molecular characteristics of Clostridioides difficile NAP1/BI/027/ST1 clinical isolates in the People's Republic of China |
| Q37681661 | Whole genome sequences of three Clade 3 Clostridium difficile strains carrying binary toxin genes in China |
| Q35898112 | Whole genome sequencing reveals potential spread of Clostridium difficile between humans and farm animals in the Netherlands, 2002 to 2011. |
| Q64066379 | Whole-genome sequencing reveals nosocomial Clostridioides difficile transmission and a previously unsuspected epidemic scenario |
| Q53715705 | Zoonotic Transfer of Clostridium difficile Harboring Antimicrobial Resistance between Farm Animals and Humans. |
| Q30575525 | [Current data and trends on the development of antibiotic resistance of Clostridium difficile]. |